文献速递乳腺癌放疗

体积至关重要:丹麦乳腺癌协作组III期随机部分乳腺照射试验中乳腺硬结与受照乳腺体积相关

Volume matters: Breast induration is associated with irradiated breast volume in the Danish Breast Cancer Group phase III randomized Partial Breast Irradiation trial.
PubMed 文献 · Radiother Oncol · 2022-10-17

该研究基于丹麦乳腺癌协作组(DBCG)部分乳腺照射(PBI)III期随机试验,分析433例PBI和432例全乳照射(WBI)患者的治疗计划与乳腺硬结数据。结果显示,3年2-3级乳腺硬结发生率PBI组为5%、WBI组为10%,且硬结频率随受照乳腺体积增加而显著升高,支持小体积照射和PBI。

要点

  • PBI组3年2-3级乳腺硬结发生率为5%,WBI组为10%。
  • CTVp_breast受≥40 Gy的中位体积比例PBI组为24.9%,WBI组为59.8%。
  • 模型显示≥40 Gy照射体积177 mL和426 mL分别对应5%和10%硬结风险。

核心结论

  • 乳腺硬结频率随受照乳腺体积增加而显著升高,强烈支持小体积照射和PBI。
  • 受照乳腺体积而非乳腺本身大小是硬结的危险因素。
  • 这是首次将40 Gy受照乳腺体积与乳腺硬结直接关联的报告。

研究设计与样本

  • 基于DBCG PBI III期随机试验,从丹麦放疗计划数据库获取治疗计划数据,从DBCG数据库获取乳腺硬结数据。
  • PBI组433例,WBI组432例。
  • 采用逻辑回归评估受≥40 Gy照射乳腺体积与硬结频率的关系。

主要发现

  • CTVp_breast中位体积PBI组为710 mL(IQR 467-963 mL),WBI组为666 mL(IQR 443-1012 mL)(p=0.98)。
  • CTVp_breast受≥40 Gy的中位体积比例PBI组为24.9%(IQR 18.6-32.6%),WBI组为59.8%(IQR 53.6-68.5%)。
  • 3年2-3级乳腺硬结发生率PBI组为5%,WBI组为10%。
  • 模型显示,CTVp_breast受≥40 Gy体积177 mL(95%CI 94-260 mL)对应5%硬结风险,426 mL(95%CI 286-567 mL)对应10%硬结风险。

关键数值与推荐

  • CTVp_breast受≥40 Gy体积177 mL(95%CI 94-260 mL)对应5%乳腺硬结风险。
  • CTVp_breast受≥40 Gy体积426 mL(95%CI 286-567 mL)对应10%乳腺硬结风险。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The relation between breast induration grade 2-3 at 3 years after radiation therapy and irradiated breast volume was investigated for patients in the Danish Breast Cancer Group (DBCG) Partial Breast Irradiation (PBI) trial. METHODS Treatment plan data was obtained from the Danish radiotherapy plan database. Dosimetric parameters for breast and organs at risk were determined. Breast induration data was obtained from the DBCG database. The volume of the whole breast (CTVp_breast) treated to various dose levels was determined for treatment plans in both arms. Logistic regression was used to assess the frequency of induration on breast volume irradiated to ≥40 Gy. RESULTS PBI and WBI was given to 433 and 432 patients, respectively. Median and interquartile ranges (IQR) for CTVp_breast were 710 mL (467-963 mL; PBI) and 666 mL (443-1012 mL; WBI) (p = 0.98). Median and IQR for CTVp_breast treated to ≥40 Gy was 24.9% (18.6-32.6%; PBI) and 59.8% (53.6-68.5%; WBI). Grade 2-3 induration was observed in 5% (PBI) and 10% (WBI) of the patients. A dose-response relationship was established between irradiated breast volume and frequency of breast induration. From the model, 5% and 10% risks of breast induration were observed for ≥40 Gy delivered to CTVp_breast volumes of 177 mL (95%CI, 94-260 mL) and 426 mL (95%CI, 286-567 mL), respectively. CONCLUSION The frequency of breast induration increased significantly with increasing irradiated breast volume, strongly favouring small volumes and PBI. Thus, treated breast volume - not the breast size itself - is the risk factor for induration. This is the first report directly linking the 40 Gy irradiated breast volume to breast induration.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Thomsen MS, Alsner J, Nielsen HM, et al. Volume matters: Breast induration is associated with irradiated breast volume in the Danish Breast Cancer Group phase III randomized Partial Breast Irradiation trial. Radiother Oncol. 2022. PMID: 36265685. doi:10.1016/j.radonc.2022.09.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。